| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9354 |
| Human Intestinal Absorption | HIA+ | 0.7258 |
| Caco-2 Permeability | Caco2+ | 0.5655 |
| P-glycoprotein Substrate | Non-substrate | 0.8706 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9838 |
| Non-inhibitor | 0.9871 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9389 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5268 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8543 |
| CYP450 2D6 Substrate | Non-substrate | 0.8889 |
| CYP450 3A4 Substrate | Non-substrate | 0.7916 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8913 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9239 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9533 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9355 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9619 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9380 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9438 |
| Non-inhibitor | 0.9849 |
| AMES Toxicity | Non AMES toxic | 0.8735 |
| Carcinogens | Carcinogens | 0.5403 |
| Fish Toxicity | Low FHMT | 0.8522 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.8767 |
| Honey Bee Toxicity | High HBT | 0.7842 |
| Biodegradation | Ready biodegradable | 0.9430 |
| Acute Oral Toxicity | III | 0.5882 |
| Carcinogenicity (Three-class) | Non-required | 0.6246 |